Medicine pil








Glossary-electronic Medicines Compendium (eMC)

10/14/2014
03:31 | Author: Nicholas Clark

Medicine pil
Glossary-electronic Medicines Compendium (eMC)

PIL stands for Patient Information Leaflet (known as Package Leaflet or PL) and is the leaflet that is included in the pack with a medicine. The PIL is written by the.

PILs have to contain specific headings, but sometimes the order might differ. These are the usual headings and the information that is included in each section.

This section is only on SPCs for radiopharmaceutical products. It ls you how to get rid of any unused or waste products safely.

What could happen to you if you take or use too much of the medicine?

How does the medicine affect your body and what does your body do to the medicine?

How and where to store your medicine.

This is a government agency which approves and licenses medicines, allowing them to be prescribed in European countries.

Comments (1)Read more



Cervarix - Patient Information Leaflet (PIL) - (eMC)

12/13/2014
01:02 | Author: Jeremy Rodriguez

Medicine pil
Cervarix - Patient Information Leaflet (PIL) - (eMC)

The Patient Information Leaflet (PIL) is the leaflet included in the pack with a medicine. It is written for patients and gives information about.

Please check that this is the correct company before contacting them. Why? human papillomavirus vaccine. Before you contact this company : often several companies will market medicines with the same active ingredient.

POM - Prescription Only Medicine.

Sign up to bookmark this PIL (already have an account? Log in ).

Find medicines with the same active ingredients.

This site uses cookies. By continuing to browse the site you are agreeing to our policy on the use of cookies. Find out more here.

Having problems opening this PDF? Download Acrobat Reader.

Sign up to this PIL (already have an account? Log in ).

Download Patient Information Leaflet.

Last Updated on eMC 07-Jan-2014 View changes| GlaxoSmithKline UK Contact details Cervarix (SPC).

Please click on the link to the left to view the PIL in PDF format.

It is possible that the leaflet in your medicine pack may differ from this version because it may have been updated since your medicine was packaged. The Patient Information Leaflet (PIL) is the leaflet included in the pack with a medicine. It is written for patients and gives information about taking or using a medicine.

Find medicines from the same company.

Stockley Park West, Uxbridge, Middlesex, UB11 1BT.

Comments (0)

X-PIL - electronic Medicines Compendium

10/12/2014
01:47 | Author: Steven Lewis

Medicine pil
X-PIL - electronic Medicines Compendium

X-PIL ensures that patient information leaflets (PILs) supplied with medicines are accessible to everyone, including those with sight problems. X-PIL is a leading.

X-PIL ensures that patient information leaflets (PILs) supplied with medicines are accessible to everyone, including those with sight problems.

Quick Search for Medicines.

X-PIL is a leading source of reliable and up-to-date information on UK medicines. The web site is managed by Datapharm Communications Limited. All the PILs on the web site are supplied and updated regularly by UK pharmaceutical companies.

All the PILs on the X-PIL web site can be viewed in different sizes and are designed for screen readers.

The Royal National Institute of Blind People (RNIB) Medicine Leaflet Line can also provide PILs in a number of physical formats:

The RNIB Medicine Leaflet Line is free to use and available 24 hours a day, 7 days a week. Please call them on 0800 198 5000.

X-PIL complements the electronic Medicines Compendium (eMC) (new window) web site. The eMC already has patient and prescribing information for thousands of medicines and is used widely by the public, doctors, pharmacists and nurses.

You may also be able to listen to a PIL when you call the Medicine Leaflet Line.

This site uses cookies. By continuing to browse the site you are agreeing to our policy on the use of cookies. Find out more here.

Comments (0)

SPC and PILs - Medicines and Healthcare products Regulatory

8/11/2014
03:16 | Author: Chloe Allen

Medicine pil
SPC and PILs - Medicines and Healthcare products Regulatory

Every medicine pack includes a patient information leaflet (PIL), which provides information on using the medicine safely. PILs are based on the Summaries of.

In Safety information.

Market authorisation holders have 6 months to exhaust stocks after they cancel their product so the PILs will still be available during this period, with an extra 6 months for patients who still have the product in their cupboards. Product information for cancelled marketing authorisations will stay on the website for a year after they are cancelled.

Enter a product or active substance:

MHRA holds data for medicines that are licensed at national level. For product information on these medicines, please consult the European Medicines Agency (external link). Some medicines are licensed centrally by the European Medicines Agency (EMA).

Head office : 151 Buckingham Palace Road, Victoria, London, SW1W 9SZ General enquiries: To contact us about this website, use our feedback form.

Every medicine pack includes a patient information leaflet (PIL), which provides information on using the medicine safely. PILs are based on the Summaries of Product Characteristics (SPCs) which are a description of a medicinal product’s properties and the conditions attached to its use.

This information is arranged in an A-Z list by active substance. You can also use the search box on the left to find a medicine by generic name or brand name.

Home Safety information Medicines information SPC and PILs.

Search SPC and PILs.

PILS can be updated several times through the product’s lifecycle, so the PIL found with products when purchased or dispensed could be different. This is the most up-to-date information for a medicine according to its licence history.

If you have any questions or comments on this list of product information, please contact our Customer Services Team.

Comments (0)

Patient information leaflet (PIL) of the month - Medicines and

6/10/2014
05:05 | Author: Molly Young

Medicine pil
Patient information leaflet (PIL) of the month - Medicines and

Home How we regulate Medicines Labels, patient information leaflets and packaging Patient information leaflet (PIL) of the month.

Home How we regulate Medicines Labels, patient information leaflets and packaging Patient information leaflet (PIL) of the month MHRA pages:

Patient information leaflets (PILs) are changing.

Other sites: (open in a new window)

Marketing authorisation holders may find it helpful to use this scoring system to help develop better quality patient information leaflets: Quality criteria for patient information leaflets (18Kb) A selection of patient information leaflets demonstrating best practice:. The leaflets in this scheme have been supported by a user test carried out in compliance with article 59(3) of Council Directive 2001/83/EC. The Commission on Human Medicines Expert Advisory Group on Patient Information has developed a quality scoring system to help identify by means of a numerical score good quality patient information. However, quality of the information can be assessed in other ways. Leaflet included in this initiative have scored significantly higher in the new layout and design than previously.

Head office : 151 Buckingham Palace Road, Victoria, London, SW1W 9SZ General enquiries: To contact us about this website, use our feedback form.

In Medicines.

Any enquiries on this subject area should be directed to.

All leaflets associated with this scheme are published with the agreement of the marketing authorisation holder responsible for the medicine to which they relate. To promote this new initiative and share best practice, we are publishing a series of examples below to illustrate improvements and to aid learning. PILs are improving in quality as a result of new legal obligations on manufacturers to test the documents on potential patients. Testing makes sure that the presentation of the information enables patients to find and understand key messages for safe use of the medicine within the PIL and thereby enable them to use the medicine safely and effectively.

Comments (0)